Atezolizumab and granzyme B as immunotoxin against PD-L1 antigen; an insilico study
Authors (first, second and last of 10)

In Silico Pharmacology provides a forum for research articles at the cross-roads of computation, pharmacology, toxicology and pharmaceutics, and is relevant to all areas of basic science and therapeutics. Within this context, neuroscience and drug discovery are areas of special interest to the journal, as are state-of-the-art multiscale modelling, informatics, artificial intelligence, and big data.